Haematological changes after switching from stavudine to zidovudine in HIV-infected children receiving highly active antiretroviral therapy

• المؤلفون الرئيسيون: Aurpibul L., Puthanakit T., Sirisanthana T., Sirisanthana V.
• التنسيق: مقال
• اللغة: English
• منشور في: 2014
• الوصول للمادة أونلاين: http://www.scopus.com/inward/record.url?eid=2-s2.0-42049088552&partnerID=40&md5=4cc7941d5433e33a500b755681bc43c9; http://www.ncbi.nlm.nih.gov/pubmed/18331562; http://cmuir.cmu.ac.th/handle/6653943832/2450
• المؤسسة: Chiang Mai University

Objective: In resource-limited countries, stavudine (d4T) is commonly used as part of the initial highly active antiretroviral therapy (HAART) regimen. Many patients who subsequently develop lipodystrophy switch from d4T to zidovudine (ZDV), a drug that can be myelotoxic. We aimed to study the spect...